VALENTINA
SATTA
Contratada con cargo a proyecto
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (9)
2023
-
Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1aWT/A1783V mice, a preclinical model of Dravet syndrome
Neuropharmacology, Vol. 237
-
Endocannabinoid-Binding Receptors as Drug Targets
Methods in molecular biology (Clifton, N.J.), Vol. 2576, pp. 67-94
-
Retinal Tissue Shows Glial Changes in a Dravet Syndrome Knock-in Mouse Model
International Journal of Molecular Sciences, Vol. 24, Núm. 3
2022
-
Editorial: Cannabinoids as potential treatment for neurological diseases
Frontiers in Neuroscience
-
Preclinical investigation of β-caryophyllene as a therapeutic agent in an experimental murine model of Dravet syndrome
Neuropharmacology, Vol. 205
2021
-
Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments
Frontiers in Molecular Neuroscience, Vol. 13
2018
-
Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders
Biochemical Pharmacology, Vol. 157, pp. 85-96
-
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists
Bioorganic and Medicinal Chemistry, Vol. 26, Núm. 1, pp. 295-307
2016
-
Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome
Pharmacology Research and Perspectives, Vol. 4, Núm. 2